Sharon Mates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sharon mates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sharon Mates Today - Breaking & Trending Today

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript February 22, 2024 Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […] ....

Dow Jones Dividend Stocks According , Get Easy Work Visa , Intra Cellular Therapies , Juan Sanchez , Intra Cellular Therapies , Sharon Mates , Forward Looking Statements , Fourth Quarter , Mark Neumann ,

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) CEO Sells $5,068,027.25 in Stock

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) CEO Sharon Mates sold 75,361 shares of Intra-Cellular Therapies stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $67.25, for a total value of $5,068,027.25. Following the transaction, the chief executive officer now directly owns 1,050,309 shares in the […] ....

New Zealand General , New Zealand , United States , Robertw Baird , Securities Exchange Commission , Cellular Therapies Inc , Wellington Management Group , Vanguard Group Inc , Norges Bank , Royal Bank , Blackrock Inc , Needham Company , Intra Cellular Therapies , Get Free Report , Exchange Commission , Sharon Mates , Cellular Therapies , Management Group , Partners Management , Intra Cellular Therapies Daily , Nasdaq Itci , Insider Trading , Nsider Trades ,

Intra-Cellular Therapies Inc CEO Sharon Mates Sells 191,362 Shares

Sharon Mates, the Chairman, President & CEO of Intra-Cellular Therapies Inc (NASDAQ:ITCI), has sold 191,362 shares of the company on January 18, 2024, according to a recent SEC Filing. ....

Intra Cellular Therapies Inc , Iopharmaceutical Company , Nsider Transaction , Sharon Mates , Nsider Transactions ,

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) CEO Sells $4,427,509.23 in Stock

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) CEO Sharon Mates sold 67,917 shares of Intra-Cellular Therapies stock in a transaction on Thursday, January 18th. The stock was sold at an average price of $65.19, for a total transaction of $4,427,509.23. Following the completion of the transaction, the chief executive officer now owns 1,050,309 shares […] ....

United States , New Zealand General , New Zealand , Robertw Baird , Vanguard Group Inc , Cellular Therapies Inc , Wellington Management Group , Blackrock Inc , Cantor Fitzgerald , Jpmorgan Chase Co , Goldman Sachs Group , Needham Company , Intra Cellular Therapies , Get Free Report , Sharon Mates , Cellular Therapies Trading Down , Cellular Therapies , Management Group , Street Corp , Intra Cellular Therapies Daily , Nasdaq Itci , Insider Trading , Nsider Trades ,